Avista: Discounted Valuation Offers Upside Despite Financing Challenges

Manimala Misra 61 Followers Follow Summary Avista is rated a long-term buy at $35.49, reflecting undervaluation relative to sector medians and a forward P/E of 13.7x. AVA's ~$3.44 billion infrastructure investment (2026–2030) targets 4–6% utility earnings growth, but success depends on regulatory approvals and disciplined capital management. Risks include financing needs, potential shareholder dilution (2.7% YoY in H1 2026), and regulatory uncertainty impacting cost recovery and EPS growth. A 5.54% dividend yield and improving utility earnings support the investment case, but further upside relies on effective execution and favorable regulatory outcomes. zhaojiankang/iStock via Getty Images Investment Thesis Avista Corporation ( AVA ), at its current price, is an attractive investment opportunity from a long-term perspective. Its current valuation may not reflect its future earnings potential. The company is improving its utility earnings. It has also This article was written by Manimala Misra 61 Followers Follow Apart from my academic training in Biology and Chemistry, I hold a Ph.D. in Environmental Science with a specialization in Bio-Medical Waste Management. My areas of research and analysis include clean technologies, renewable energy, pollution control systems, and environmental compliance solutions. I follow companies operating in these sectors using a research-driven approach that integrates regulatory trends, sustainability metrics, and scientific evaluation to assess long-term growth opportunities, risks, and value potential. By actively tracking and analyzing companies engaged in environmental management, renewable energy, and green technologies, my work aims to blend scientific depth with market analysis to provide practical insights that help investors understand financial outcomes and emerging opportunities. At a personal level, I also provide free stock market consultation to a select group of friends, relatives, and former colleagues. I am associated with Seeking Alpha analyst Eudaemon Research. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.